AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35397306 — intervention group
Group type: EXPERIMENTAL
Intervention: Myofascial therapy
Number of subjects: 44
Study 35397306 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesitherapy
Number of subjects: 44
Study 35397306 — intervention group
Group type: COMPARATOR
Intervention: Control group (therapeutic exercise program)
Number of subjects: 44
Study 32488856 — intervention group
Group type: EXPERIMENTAL
Intervention: Coriandrum sativum extract (300 mg/kg/day)
Number of subjects: 4
Study 32488856 — intervention group
Group type: COMPARATOR
Intervention: Ischaemia/reperfusion injury (IRI)
Number of subjects: 4
Study 32488856 — intervention group
Group type: EXPERIMENTAL
Intervention: Coriandrum sativum extract
Number of subjects: 4
Study 32488856 — intervention group
Group type: COMPARATOR
Intervention: Sham group
Number of subjects: 4
Study 32488856 — intervention group
Group type: EXPERIMENTAL
Intervention: IRI + Coriandrum sativum
Number of subjects: 4
Study 34330252 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive information (narrative condition)
Number of subjects: 180
Study 34330252 — intervention group
Group type: COMPARATOR
Intervention: Non-interactive information (narrative condition)
Number of subjects: 180
Study 34330252 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive information (data visualization condition)
Number of subjects: 180
Study 34330252 — intervention group
Group type: COMPARATOR
Intervention: Non-interactive information (data visualization condition)
Number of subjects: 180
Study 32030921 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-day proton pump inhibitor (PPI)-based standard triple therapy (STT; PPI-clarithromycin-amoxicillin)
Number of subjects: 369
Study 32030921 — intervention group
Group type: EXPERIMENTAL
Intervention: 14-day proton pump inhibitor (PPI)-based standard triple therapy (STT; PPI-clarithromycin-amoxicillin)
Number of subjects: 369
Study 32030921 — intervention group
Group type: EXPERIMENTAL
Intervention: Bismuth-containing quadruple therapy (second-line therapy) for 14 days
Number of subjects: 369
Study 32030921 — intervention group
Group type: COMPARATOR
Intervention: Bismuth-containing quadruple therapy (second-line therapy) for 7 days
Number of subjects: 369
Study 35850884 — intervention group
Group type: EXPERIMENTAL
Intervention: Eyebrow suspension with nylon thread (ESN)
Number of subjects: 27
Study 35850884 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal browpexy fixation (IBF)
Number of subjects: 27
Study 33834671 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral greater palatine nerve block
Number of subjects: 401
Study 32417468 — intervention group
Group type: EXPERIMENTAL
Intervention: Doctors/healthcare providers
Number of subjects: 1083
Study 32417468 — intervention group
Group type: EXPERIMENTAL
Intervention: Other healthcare-related resources (e.g., CDC, WebMD)
Number of subjects: 1083
Study 32417468 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental age increase
Number of subjects: 1083
Study 32417468 — intervention group
Group type: EXPERIMENTAL
Intervention: Concussion histories of children
Number of subjects: 1083
Study 32756053 — intervention group
Group type: EXPERIMENTAL
Intervention: Active waiting (provision of a purpose-built website; n = 20)
Number of subjects: 42
Study 32756053 — intervention group
Group type: COMPARATOR
Intervention: Passive waiting (control group; n = 22)
Number of subjects: 42
Study 34954123 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab
Number of subjects: 0
Study 33223455 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.75%
Number of subjects: 30
Study 33223455 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine 2% with 1:100,000 epinephrine
Number of subjects: 30
Study 32074281 — intervention group
Group type: EXPERIMENTAL
Intervention: Progesterone vaginal pessaries 400 mg bid
Number of subjects: 769
Study 32074281 — intervention group
Group type: COMPARATOR
Intervention: Progesterone vaginal gel 90 mg od
Number of subjects: 769
Study 33806511 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium and high density of outdoor tobacco advertising
Number of subjects: 400
Study 33806511 — intervention group
Group type: EXPERIMENTAL
Intervention: Proximity to outdoor tobacco advertising
Number of subjects: 400
Study 33806511 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher density and proximity to outdoor tobacco advertising in poorer neighborhoods
Number of subjects: 400
Study 33263359 — intervention group
Group type: EXPERIMENTAL
Intervention: office‐based vergence/accommodative therapy with home reinforcement
Number of subjects: 1289
Study 33263359 — intervention group
Group type: COMPARATOR
Intervention: base‐in prism reading glasses
Number of subjects: 1289
Study 33263359 — intervention group
Group type: COMPARATOR
Intervention: office‐based vergence accommodative therapy
Number of subjects: 1289
Study 33263359 — intervention group
Group type: COMPARATOR
Intervention: base‐in prism glasses
Number of subjects: 1289
Study 35997144 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous non-invasive arterial pressure (CNAP)
Number of subjects: 106
Study 35997144 — intervention group
Group type: COMPARATOR
Intervention: Non-invasive blood pressure (NIBP)
Number of subjects: 106
Study 35997144 — intervention group
Group type: EXPERIMENTAL
Intervention: CNAP
Number of subjects: 106
Study 34226708 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy choice intervention using a dietary prime
Number of subjects: 0
Study 32396179 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment with open reduction and internal plate fixation (n=38)
Number of subjects: 82
Study 32396179 — intervention group
Group type: COMPARATOR
Intervention: Nonsurgical treatment with functional bracing (n=44)
Number of subjects: 82
Study 37436828 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab 162 mg weekly
Number of subjects: 20
Study 37436828 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 37436828 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous-tocilizumab
Number of subjects: 20
Study 37436828 — intervention group
Group type: COMPARATOR
Intervention: Placebo-tocilizumab
Number of subjects: 20
Study 37436828 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab
Number of subjects: 20
Study 33323787 — intervention group
Group type: EXPERIMENTAL
Intervention: Neostigmine
Number of subjects: 200
Study 33323787 — intervention group
Group type: COMPARATOR
Intervention: Sugammadex
Number of subjects: 200
Study 32371711 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional Endoscopic Sinus Surgery (ESS)
Number of subjects: 44
Study 32371711 — intervention group
Group type: COMPARATOR
Intervention: Balloon Sinuplasty
Number of subjects: 44
Study 36104702 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaporized nicotine products (VNPs) - pod (40 mg/mL nicotine salt) and tank device (18 mg/mL freebase nicotine)
Number of subjects: 1058
Study 36104702 — intervention group
Group type: COMPARATOR
Intervention: Nicotine replacement therapy (NRT) - gum or lozenge (4 mg)
Number of subjects: 1058
Study 33099189 — intervention group
Group type: EXPERIMENTAL
Intervention: Influencer-high group (idealised imagery alongside high 'like'/follow metrics)
Number of subjects: 111
Study 33099189 — intervention group
Group type: EXPERIMENTAL
Intervention: Influencer-low group (idealised imagery adjusted for low popularity metrics)
Number of subjects: 111
Study 33099189 — intervention group
Group type: COMPARATOR
Intervention: Nature control group with matched low‐popularity metrics
Number of subjects: 111
Study 33224416 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen (10mg/kg)
Number of subjects: 140
Study 33224416 — intervention group
Group type: COMPARATOR
Intervention: Paracetamol (15mg/kg)
Number of subjects: 140
Study 35988360 — intervention group
Group type: EXPERIMENTAL
Intervention: CIPRO+FLUO (ciprofloxacin 0.3 % and fluocinolone acetonide 0.025 % otic solution)
Number of subjects: 30
Study 35988360 — intervention group
Group type: EXPERIMENTAL
Intervention: CIPRO (ciprofloxacin 0.3 % otic solution)
Number of subjects: 30
Study 35988360 — intervention group
Group type: EXPERIMENTAL
Intervention: FLUO (fluocinolone acetonide 0.025 % otic solution)
Number of subjects: 30
Study 32687890 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound guidance during IUD insertion
Number of subjects: 400
Study 34593706 — intervention group
Group type: EXPERIMENTAL
Intervention: Airway Pressure Release Ventilation
Number of subjects: 90
Study 34593706 — intervention group
Group type: COMPARATOR
Intervention: Low Tidal Volume Ventilation
Number of subjects: 90
Study 33247625 — intervention group
Group type: EXPERIMENTAL
Intervention: Vidian Neurectomy (VN)
Number of subjects: 21
Study 33247625 — intervention group
Group type: COMPARATOR
Intervention: Control Eye (no intervention)
Number of subjects: 21
Study 35177042 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-faceted intervention including patient education brochure and personalized letter with Bruyere's PPI deprescribing algorithm sent to GPs.
Number of subjects: 33000
Study 35177042 — intervention group
Group type: COMPARATOR
Intervention: Single intervention where only GPs received the letter and algorithm.
Number of subjects: 33000
Study 35177042 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control arm).
Number of subjects: 33000
Study 35177042 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-faceted intervention
Number of subjects: 33000
Study 35177042 — intervention group
Group type: EXPERIMENTAL
Intervention: Incremental cost-utility ratio using EQ-5D-5L scale.
Number of subjects: 33000
Study 35177042 — intervention group
Group type: EXPERIMENTAL
Intervention: Acid rebound measured using the Gastroesophageal Reflux Disease Impact Scale.
Number of subjects: 33000
Study 35177042 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients' attitudes towards deprescribing measured using the French rPATD.
Number of subjects: 33000
Study 34939004 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise is Medicine (EIM) intervention framework (mHealth components plus twice‐weekly small‐group directed exercise sessions)
Number of subjects: 56
Study 34939004 — intervention group
Group type: COMPARATOR
Intervention: Mobile health (mHealth) group (wearable activity trackers and fitness professional counseling)
Number of subjects: 56
Study 35717241 — intervention group
Group type: EXPERIMENTAL
Intervention: Clarithromycin (1 gr intravenously once daily for 4 days)
Number of subjects: 110
Study 35717241 — intervention group
Group type: COMPARATOR
Intervention: Placebo (intravenously once daily for 4 days)
Number of subjects: 110
Study 35717241 — intervention group
Group type: EXPERIMENTAL
Intervention: Clarithromycin
Number of subjects: 110
Study 35717241 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study 33120640 — intervention group
Group type: EXPERIMENTAL
Intervention: Mohindra's near retinoscopy (MNR)
Number of subjects: 101
Study 33120640 — intervention group
Group type: COMPARATOR
Intervention: Post cycloplegic refraction (PCRef)
Number of subjects: 101
Study 33120640 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation analysis
Number of subjects: 101
Study 33120640 — intervention group
Group type: EXPERIMENTAL
Intervention: Agreement analysis
Number of subjects: 101
Study 33120640 — intervention group
Group type: EXPERIMENTAL
Intervention: Regression analysis
Number of subjects: 101
Study 32299251 — intervention group
Group type: EXPERIMENTAL
Intervention: Aminophylline treatment
Number of subjects: 0
Study 32299251 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33752164 — intervention group
Group type: EXPERIMENTAL
Intervention: sprifermin 100 µg every 6 months (q6mo)
Number of subjects: 161
Study 33752164 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 161
Study 34874523 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive Dynamic Scalp Acupuncture (IDSA)
Number of subjects: 660
Study 34874523 — intervention group
Group type: COMPARATOR
Intervention: Simple Combination Therapy (SCT)
Number of subjects: 660
Study 34874523 — intervention group
Group type: COMPARATOR
Intervention: Traditional Scalp Acupuncture (TSA)
Number of subjects: 660
Study 32514040 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal administration of oxytocin (OT) in the minimal social contact (MSC) condition
Number of subjects: 0
Study 32514040 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal administration of oxytocin (OT) in the no-social-contact (NoC) condition
Number of subjects: 0
Study 32514040 — intervention group
Group type: COMPARATOR
Intervention: Placebo in the minimal social contact (MSC) condition
Number of subjects: 0
Study 32514040 — intervention group
Group type: COMPARATOR
Intervention: Placebo in the no-social-contact (NoC) condition
Number of subjects: 0
Study 36280407 — intervention group
Group type: EXPERIMENTAL
Intervention: NRD assisted Ilizarov technique
Number of subjects: 48
Study 36280407 — intervention group
Group type: COMPARATOR
Intervention: Traditional bone transport technique
Number of subjects: 48
Study 34342585 — intervention group
Group type: EXPERIMENTAL
Intervention: Ecological momentary assessment (EMA) intervention across 30 days
Number of subjects: 952
Study 34342585 — intervention group
Group type: EXPERIMENTAL
Intervention: Event-contingent prompts after engaging in substance use
Number of subjects: 952
Study 34342585 — intervention group
Group type: EXPERIMENTAL
Intervention: EMA interventions focusing on psychological and behavioral outcomes
Number of subjects: 952
Study 35019769 — intervention group
Group type: EXPERIMENTAL
Intervention: Listerine mouthwash
Number of subjects: 153
Study 35019769 — intervention group
Group type: EXPERIMENTAL
Intervention: Biotène dry mouth oral rinse
Number of subjects: 153
Study 33001229 — intervention group
Group type: EXPERIMENTAL
Intervention: MASK (flow‐resistive mask)
Number of subjects: 23
Study 33001229 — intervention group
Group type: EXPERIMENTAL
Intervention: IMT (pressure threshold loading inspiratory muscle training)
Number of subjects: 23
Study 33001229 — intervention group
Group type: COMPARATOR
Intervention: CON (HIIT only)
Number of subjects: 23
Study 32820573 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidemiological agent-based models (ABMs) such as AceMod for the COVID-19 epidemic in Australia
Number of subjects: 0
Study 32820573 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidemiological agent-based models (ABMs)
Number of subjects: 0
Study 35536364 — intervention group
Group type: EXPERIMENTAL
Intervention: Free fibular graft group (FFG)
Number of subjects: 182
Study 35536364 — intervention group
Group type: EXPERIMENTAL
Intervention: Free vascularized fibular graft group (FVFG)
Number of subjects: 182
Study 35536364 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous iliac bone group (ABG)
Number of subjects: 182
Study 35536364 — intervention group
Group type: EXPERIMENTAL
Intervention: β-tricalcium bioceramics phosphate graft (β-TCPG)
Number of subjects: 182
Study 35536364 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 182
Study 34265462 — intervention group
Group type: EXPERIMENTAL
Intervention: ChAdOx1 nCoV-19 (1 dose)
Number of subjects: 8165
Study 34265462 — intervention group
Group type: EXPERIMENTAL
Intervention: mRNA BNT162b2 (1 dose)
Number of subjects: 8165
Study 34265462 — intervention group
Group type: EXPERIMENTAL
Intervention: mRNA BNT162b2 (2 doses)
Number of subjects: 8165
Study 34265462 — intervention group
Group type: EXPERIMENTAL
Intervention: mRNA-1273 (1 dose)
Number of subjects: 8165
Study 34265462 — intervention group
Group type: EXPERIMENTAL
Intervention: mRNA-1273 (2 doses)
Number of subjects: 8165
Study 34265462 — intervention group
Group type: COMPARATOR
Intervention: Non-vaccinated HCWs
Number of subjects: 8165
Study 33338947 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin plus metformin
Number of subjects: 5
Study 33338947 — intervention group
Group type: COMPARATOR
Intervention: Metformin
Number of subjects: 5
Study 32504574 — intervention group
Group type: EXPERIMENTAL
Intervention: Bictegravir 50 mg, emtricitabine 200 mg, and tenofovir alafenamide 25 mg
Number of subjects: 1274
Study 32504574 — intervention group
Group type: COMPARATOR
Intervention: Dolutegravir 50 mg, abacavir 600 mg, and lamivudine 300 mg
Number of subjects: 1274
Study 32504574 — intervention group
Group type: COMPARATOR
Intervention: Dolutegravir 50 mg, emtricitabine 200 mg, and tenofovir alafenamide 25 mg
Number of subjects: 1274
Study 32504574 — intervention group
Group type: EXPERIMENTAL
Intervention: Bictegravir, emtricitabine, and tenofovir alafenamide
Number of subjects: 1274
Study 32504574 — intervention group
Group type: COMPARATOR
Intervention: Dolutegravir, abacavir, and lamivudine
Number of subjects: 1274
Study 32504574 — intervention group
Group type: COMPARATOR
Intervention: Dolutegravir, emtricitabine, and tenofovir alafenamide
Number of subjects: 1274
Study 35987487 — intervention group
Group type: EXPERIMENTAL
Intervention: Trauma-Focused Therapy (TFT) - Prolonged Exposure or Cognitive Processing Therapy
Number of subjects: 420
Study 35987487 — intervention group
Group type: COMPARATOR
Intervention: Non-Trauma-Focused Therapy (NTFT) - Present Centered Therapy (PCT)
Number of subjects: 420
Study 34001622 — intervention group
Group type: EXPERIMENTAL
Intervention: Heightened awareness of immigration detention policies
Number of subjects: 0
Study 34001622 — intervention group
Group type: EXPERIMENTAL
Intervention: Heightened awareness of nonjudicial removals
Number of subjects: 0
Study 32668990 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous nephrolithotomy (PNL)
Number of subjects: 80
Study 32668990 — intervention group
Group type: COMPARATOR
Intervention: Extracorporeal shock wave lithotripsy (SWL)
Number of subjects: 80
Study 32668990 — intervention group
Group type: COMPARATOR
Intervention: SWL
Number of subjects: 80
Study 32668990 — intervention group
Group type: EXPERIMENTAL
Intervention: PNL
Number of subjects: 80
Study 33522583 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor skills in toddlers with ASD with delayed receptive language (RL) and expressive language (EL) development
Number of subjects: 38
Study 33522583 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor skills in toddlers with ASD with typical RL and EL development
Number of subjects: 38
Study 33522583 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor skills in toddlers with ASD
Number of subjects: 38
Study 33522583 — intervention group
Group type: COMPARATOR
Intervention: Motor skills in toddlers with TD
Number of subjects: 38
Study 33323432 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous propofol
Number of subjects: 80
Study 33323432 — intervention group
Group type: COMPARATOR
Intervention: Inhalational desflurane
Number of subjects: 80
Study 36336284 — intervention group
Group type: EXPERIMENTAL
Intervention: Covered Stents (CS)
Number of subjects: 174
Study 36336284 — intervention group
Group type: COMPARATOR
Intervention: Bare Metal Stents (BMS)
Number of subjects: 174
Study 33078216 — intervention group
Group type: EXPERIMENTAL
Intervention: Active suction (AS) drainage
Number of subjects: 3430
Study 33078216 — intervention group
Group type: COMPARATOR
Intervention: Passive gravity (PG) drainage
Number of subjects: 3430
Study 32059587 — intervention group
Group type: EXPERIMENTAL
Intervention: 90-minute educational intervention on breast cancer screening
Number of subjects: 183
Study 32059587 — intervention group
Group type: COMPARATOR
Intervention: Educational materials provided at the end of the study (Control)
Number of subjects: 183
Study 32059587 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention
Number of subjects: 183
Study 35320927 — intervention group
Group type: EXPERIMENTAL
Intervention: ADD (pecans 68 g/d)
Number of subjects: 93
Study 35320927 — intervention group
Group type: EXPERIMENTAL
Intervention: SUB (pecans 68 g/d with isocaloric substitution)
Number of subjects: 93
Study 35320927 — intervention group
Group type: COMPARATOR
Intervention: Control (nut-free)
Number of subjects: 93
Study 33527654 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambulatory medication intervention (diuretic up-titration PRN)
Number of subjects: 66
Study 33226277 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 239
Study 33226277 — intervention group
Group type: EXPERIMENTAL
Intervention: 4,200 IU Vitamin D3
Number of subjects: 239
Study 33226277 — intervention group
Group type: EXPERIMENTAL
Intervention: 16,800 IU Vitamin D3
Number of subjects: 239
Study 33226277 — intervention group
Group type: EXPERIMENTAL
Intervention: 28,000 IU Vitamin D3
Number of subjects: 239
Study 35361169 — intervention group
Group type: EXPERIMENTAL
Intervention: Needle aspiration of calcific deposits (NACD)
Number of subjects: 140
Study 35361169 — intervention group
Group type: COMPARATOR
Intervention: Extracorporeal shock wave therapy (ESWT)
Number of subjects: 140
Study 35361169 — intervention group
Group type: EXPERIMENTAL
Intervention: NACD and ESWT
Number of subjects: 140
Study 34085466 — intervention group
Group type: EXPERIMENTAL
Intervention: Joint administration of acupuncture, western and herbal medicines, and bamboo-jar-cupping (kept for 10 min), treatment conducted once a day for 2 weeks.
Number of subjects: 100
Study 34085466 — intervention group
Group type: COMPARATOR
Intervention: Conventional western medicines and Chinese herbal medicines (for anti-platelet aggregation, blood-lipid regulation, arterial plaque-stabilization, cerebral cell protection, blood pressure-lowering, and promoting blood circulation to dredge the meridian-collaterals).
Number of subjects: 100
Study 34085466 — intervention group
Group type: COMPARATOR
Intervention: Treatment group (acupuncture + cupping) vs Control group (acupuncture + conventional western and herbal medicines).
Number of subjects: 100
Study 616505834 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibre-enriched nutrition solution
Number of subjects: 120
Study 616505834 — intervention group
Group type: COMPARATOR
Intervention: Fibre-free nutrition solution
Number of subjects: 120
Study 33955809 — intervention group
Group type: EXPERIMENTAL
Intervention: 15% DTP and 5% DGP
Number of subjects: 72
Study 33955809 — intervention group
Group type: COMPARATOR
Intervention: DGP
Number of subjects: 72
Study 33955809 — intervention group
Group type: EXPERIMENTAL
Intervention: FSM and DTP
Number of subjects: 72
Study 33955809 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary treatments
Number of subjects: 72
Study 32853042 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral epicondylitis (LE) cohort
Number of subjects: 0
Study 32853042 — intervention group
Group type: COMPARATOR
Intervention: Control cohort (patients without LE)
Number of subjects: 0
Study 32853042 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral epicondylitis (LE) cohort (aged 50 to 64 years)
Number of subjects: 0
Study 32853042 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral epicondylitis (LE) cohort (aged over 65 years)
Number of subjects: 0